Tabibian James H, Girotra Mohit, Yeh Hsin-Chieh, Singh Vikesh K, Okolo Patrick I, Cameron Andrew M, Gurakar Ahmet
Division of Gastroenterology, Hepatology, and Transplant Hepatology, Johns Hopkins School of Medicine, Baltimore, MD, USA; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.
Division of Gastroenterology, Hepatology, and Transplant Hepatology, Johns Hopkins School of Medicine, Baltimore, MD, USA.
Ann Hepatol. 2015 May-Jun;14(3):340-7.
Anastomotic biliary strictures (ABS) are a significant clinical problem associated with decreased survival post-liver transplantation (LT). Contributing to the morbidity of ABS is the need for early (i.e. emergent or unplanned) repeat endoscopic retrograde cholangiopancreatographies (ER-ERCPs). Our aim was to determine clinical, operative, and endoscopic predictors of ER-ERCP in patients with ABS.
Medical records of 559 patients who underwent LT at our institution from 2000-2012 were retrospectively reviewed for pertinent data. The primary endpoint was need for ER-ERCP. Seventeen potential predictors of ER-ERCP were assessed in bivariate analyses, and those with p < 0.20 were included in multivariate regression models.
Fifty-four LT patients developed ABS and underwent a total of 200 ERCPs, of which 40 met criteria for ER-ERCP. Predictors of ER-ERCP in bivariate analyses included balloon dilation within 3 months post-LT and donation after cardiac death (both p < 0.05). Balloon dilation within 3 months post-LT was also associated with shorter ER-ERCP-free survival (p = 0.02). Moreover, a significantly higher proportion (67%) of patients who underwent balloon dilation within 3 months post-LT subsequent experienced ≥ 1 ER-ERCP (p = 0.03), and those who experienced ≥ 1 ER-ERCP had lower stricture resolution rates at the end of endoscopic therapy compared to those who did not (79 vs. 97%, p = 0.02). In multivariate analyses, balloon dilation within 3 months post-LT was the strongest predictor of ER-ERCP (OR 3.8, 95% CI 1.7-8.6, p = 0.001).
Balloon dilation of ABS within 3 months post-LT is associated with an increased risk of ER-ERCP, which itself is associated with lower ABS resolution rates. Prospective studies are needed to confirm these findings and their implications for endoscopic management and follow-up of post-LT ABS.
吻合口胆管狭窄(ABS)是肝移植(LT)术后与生存率降低相关的一个重大临床问题。早期(即急诊或非计划)重复内镜逆行胰胆管造影术(ER-ERCP)的必要性增加了ABS的发病率。我们的目的是确定ABS患者ER-ERCP的临床、手术和内镜预测因素。
回顾性分析了2000年至2012年在我院接受LT的559例患者的病历,以获取相关数据。主要终点是是否需要ER-ERCP。在双变量分析中评估了17个可能的ER-ERCP预测因素,p<0.20的因素被纳入多变量回归模型。
54例LT患者发生ABS,共接受了200次ERCP,其中40次符合ER-ERCP标准。双变量分析中ER-ERCP的预测因素包括LT术后3个月内球囊扩张和心脏死亡后捐赠(均p<0.05)。LT术后3个月内球囊扩张还与无ER-ERCP生存期缩短有关(p=0.02)。此外,LT术后3个月内接受球囊扩张的患者中,有更高比例(67%)随后经历了≥1次ER-ERCP(p=0.03),与未经历≥1次ER-ERCP的患者相比,经历≥1次ER-ERCP的患者在内镜治疗结束时狭窄缓解率更低(79%对97%,p=0.02)。在多变量分析中,LT术后3个月内球囊扩张是ER-ERCP的最强预测因素(OR 3.8,95%CI 1.7-8.6,p=0.001)。
LT术后3个月内对ABS进行球囊扩张与ER-ERCP风险增加相关,而ER-ERCP本身又与较低的ABS缓解率相关。需要进行前瞻性研究来证实这些发现及其对LT术后ABS内镜管理和随访的影响。